A detailed history of Gts Securities LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gts Securities LLC holds 103,600 shares of LLY stock, worth $82.4 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
103,600
Previous 91,400 13.35%
Holding current value
$82.4 Million
Previous $82.8 Million 10.91%
% of portfolio
0.2%
Previous 0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $1.46 Million - $1.82 Million
1,891 Added 12.89%
16,559 $14.7 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $9.85 Million - $12.3 Million
13,585 Added 1254.39%
14,668 $13.3 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $8.98 Million - $12 Million
-15,162 Reduced 93.33%
1,083 $842,000
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $5 Million - $5.9 Million
9,526 Added 141.78%
16,245 $9.47 Million
Q3 2023

Nov 15, 2023

BUY
$434.7 - $599.3 $2.92 Million - $4.03 Million
6,719 New
6,719 $3.61 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.